Results 201 to 210 of about 131,451 (349)

Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors

open access: yesPediatric Blood &Cancer, Volume 73, Issue 5, May 2026.
ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy   +5 more
wiley   +1 more source

Predictive value of primary gross tumor volume measured by MRI in response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 5, May 2026.
Abstract Background Neoadjuvant chemoradiotherapy (nCRT) is a standard treatment for locally advanced rectal cancer (LARC), yet individual tumor regression response varies considerably. Purpose This study aimed to identify clinical factors linked to tumor regression grade (TRG) after nCRT in LARC and to evaluate MRI‐measured primary gross tumor volume (
Junbiao Li   +9 more
wiley   +1 more source

A concept of equivalent‐volume concordance coefficient for comparing target volumes in radiotherapy

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 5, May 2026.
Background The significant limitation of simple volume analyses for target volumes is that they disregard the spatial distribution of non‐overlapping volumes and the surrounding dose gradient. Purpose To present a concept of equivalent‐volume concordance coefficient (CCEV) for comparing target volumes in radiotherapy, which takes into account the dose ...
Xue Ou   +7 more
wiley   +1 more source

Tetrandrine enhances radiosensitivity through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal carcinoma cells [PDF]

open access: bronze, 2017
Jun Wang   +7 more
openalex   +1 more source

Impact of Minimum Segment Width on VMAT Plan Quality for Nasopharyngeal Carcinoma. [PDF]

open access: yesDose Response
Li Z   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy